Nomura Holdings
ALXA

Nomura Holdings’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

Nomura Holdings’s Portfolio ALXA Stock Details ALXA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-21,400
Closed -$32K – 2554
2014
Q4 		$32K Hold
21,400
– – ﹤0.01% 2208
2014
Q3 		$51K Hold
21,400
– – ﹤0.01% 2623
2014
Q2 		$98K Hold
21,400
– – ﹤0.01% 2536
2014
Q1 		$97K Buy
+21,400
New +$110K ﹤0.01% 2512

Other funds holding ALXA

LPA
Lansdowne Partners Austria Vienna, Austria $29M AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
CLOS
Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return
HHMI
Howard Hughes Medical Institute Chevy Chase, Maryland $416M AUM 13.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Nomura Holdings's ALXA Position: Q2 2014 in Review

Nomura Holdings sold out of Alexza Pharmaceuticals Inc (ALXA) in Q2 2014, closing a stake of 5 shares — an estimated $22 sold.

Nomura Holdings first reported a position in ALXA in Q2 2013 and held it in 3 quarters. The position peaked at $127K in Q3 2013. 40 funds tracked by Wall St. Rank hold ALXA as of Q2 2014.

  • Nomura Holdings reported no remaining Alexza Pharmaceuticals Inc position as of Q2 2014 after selling out during the quarter.
  • Nomura Holdings sold 5 Alexza Pharmaceuticals Inc shares in Q2 2014, an estimated $22.
  • Nomura Holdings first reported a position in Alexza Pharmaceuticals Inc in Q2 2013 and held it in 3 quarters.
  • Nomura Holdings's Alexza Pharmaceuticals Inc position peaked at $127K in Q3 2013.
  • 40 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q2 2014.

Based on Nomura Holdings's 13F filing for Q2 2014, filed 13 Aug 2014.